John Theurer Cancer Center Expert Shares Significance of Pirtobrutinib FDA Approval for Mantle Cell Lymphoma
Specialist offers insight on first reversible BTK inhibitor treatment for MCL
Hackensack University Medical Center Offers an Innovative New Screening Option for Patients at High Risk for Pancreatic Cancer
First blood test on the market dedicated to the early detection of familial or hereditary pancreatic ductal adenocarcinoma
John Theurer Cancer Center at Hackensack University Medical Center Shares Key Efficacy Findings from the DREAMseq Trial in BRAF-Mutated Melanoma
Patients who received nivolumab/ipilimumab before followed by dabrafenib (Tafinlar) and trametinib (Mekinist) experienced benefits in progression-free survival
John Theurer Cancer Center and Genetic Testing Cooperative Researchers Demonstrate Value of Genomic Sequencing and Artificial Intelligence to Improve Cancer Diagnosis
Reliability shown in accurate diagnosis of blood cancer subtypes and solid tumors
Zilo+Ibr Combination Shows Promise in John Theurer Cancer Center at Hackensack University Medical Center Study
Phase 1/2 study offers encouraging results for MZL, CLL and MZL
John Theurer Cancer Center at Hackensack University Medical Center Research Helps Establish Durable Responses After KTE-X19
ZUMA-2 study long-range follow-up in relapsed/refractory mantle cell lymphoma (R/R MCL)
Researchers with John Theurer Cancer Center at Hackensack University Medical Center Publish V-FAST Trial Outcomes
Outcomes with CPX-351 plus Midostaurin in adults with newly diagnosed acute myeloid leukemia by FLT3 mutation type
MyDrug Platform Trial Addresses Mutation Challenges to Multiple Myeloma Clinical Trial Enrollment
John Theurer Cancer Center study measures efficacy and safety of daratumumab, ixazomib, pomalidomide, and dexamethasone in patients with functionally high-risk multiple myeloma
Improved Survival for B-NHL With Fludarabine Exposure Target Window Identified in John Theurer Cancer Center at Hackensack University Medical Center Research
Negative effects of Flu over and underexposure found common with body-surface areas based dosing in study presented at ASH annual meeting
John Theurer Cancer Center at Hackensack University Medical Center Research Applies Best-in-Class Liquid Biopsy Technology for Patients with Myeloid Neoplasms
Study finds targeted NGS can reliably and efficiently provide enough information in one test on the blood to help refine diagnostics in AML and MDS
John Theurer Cancer Center at Hackensack University Medical Center Researchers Co-Author ZUMA-2 Three-Year Follow-Up on CAR T-Cell for Mantle Cell Lymphoma
Longest follow-up of CAR T-Cell in MCL to date showed long-term benefits for patients
Researchers at John Theurer Cancer Center at Hackensack University Medical Center Study CLL Retreatment with Venetoclax
Retrospective outcomes and safety data study opens potential for additional therapy after initial treatment with BTKi and venetoclax
John Theurer Cancer Center at Hackensack University Medical Center Review Examines Exosomes as Source of Circulating Tumor Biomarkers
Exosomes produced by cancer cells evaluated for feasibility and potential as a minimally invasive liquid biopsy
Hackensack University Medical Center Research Applies a Novel Platform of Dual DNA/RNA Signatures Using Liquid Biopsies for Patients with AML or MDS
Study finds targeted NGS can reliably and efficiently provide in one test enough information on the blood to help refine molecular diagnostic in AML and MDS
John Theurer Cancer Center at Hackensack University Medical Center Research Demonstrates Increase in Early Onset Colorectal Cancer
Research contributes evidence of incidence increase under age 50